Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable
fuels company focused on low and negative carbon intensity products
that replace fossil fuels, today announced its financial results
for the three and nine months ended September 30, 2024.
Revenues of $81.4 million for the third quarter of 2024 reflect
strong execution by all three of the company’s operating segments,
with the California Ethanol business generating $45.0 million in
revenues, the India Biodiesel business generating $32.2 million in
revenues, and the Dairy Renewable Natural Gas (RNG) business
generating $4.2 million in revenues.
“Each of the Aemetis segments increased revenue during the third
quarter of 2024 compared to the second quarter of 2024, reflecting
underlying strength and growth,” stated Todd Waltz, Chief Financial
Officer of Aemetis. “Additionally, we anticipate substantial
revenue growth from our operating dairies and new dairies under
construction when we receive LCFS provisional pathway approvals as
well as federal Inflation Reduction Act (IRA) 45Z production tax
credits for RNG,” added Waltz.
“The approval of 20 years of Low Carbon Fuel Standard mandates
last Friday by CARB is a major milestone for renewable fuels that
directly increases revenues and earnings from each of our U.S.
businesses and projects in ethanol, biogas, SAF/RD and carbon
sequestration,” said Eric McAfee, Chairman and CEO of
Aemetis. “In addition to solid growth in our U.S. businesses,
our India subsidiary generated $112 million of revenues driven by
the one-year, cost-plus contract with government-owned oil
marketing companies that ended in Q3 2024, and we appointed a Chief
Executive Officer for the India business who is leading our work
towards an IPO of the subsidiary.”
We invite investors to review the Aemetis Corporate Presentation
on the Aemetis home page prior to the earnings call.
Today, Aemetis will host an earnings review call at 11:00 a.m.
Pacific time (PT).
Live Participant Dial In (Toll Free):
+1-888-506-0062 entry code 139838Live Participant Dial In
(International): +1-973-528-0011 entry code 139838
Webcast URL:
https://www.webcaster4.com/Webcast/Page/2211/51559
For details on the call, please visit
http://www.aemetis.com/investors/conference-calls/
Financial Results for the Three Months Ended September 30,
2024
Revenues during the third quarter of 2024 were $81.4 million
compared to $68.7 million for the third quarter of 2023. Our Keyes
plant recognized $45.0 million of revenue during the third quarter
with the production of 15.5 million gallons of ethanol. Our Dairy
Natural Gas segment sold 85,993 MMBtu from nine operating dairy
digesters and also sold 935 thousand RINs and 20 thousand metric
tons of LCFS credits to report $4.2 million of revenue during the
third quarter. Our India Biodiesel business recognized $32.2
million of revenue primarily from sales to the India Oil Marketing
Companies.
Gross profit for the third quarter of 2024 was $3.9 million,
compared to a $492 thousand profit during the third quarter of
2023.
Selling, general and administrative expenses were $7.8 million
during the third quarter of 2024 compared to $9.0 million during
the same period in 2023, the decrease in spending was driven
primarily by professional services associated with the sale of tax
credits during the third quarter of 2023.
Operating loss was $3.9 million for the third quarter of 2024,
compared to operating loss of $8.5 million for the same period in
2023.
Interest expense, excluding accretion of Series A preferred
units in the Aemetis Biogas LLC subsidiary, increased to $11.7
million during the third quarter of 2024 compared to $10.2 million
during the third quarter of 2023. Additionally, Aemetis Biogas
recognized $3.3 million of accretion of Series A preferred units
during the third quarter of 2024 compared to $7.7 million during
the third quarter of 2023.
Net loss was $17.9 million for the third quarter of 2024,
compared to net income of $30.7 million for the third quarter of
2023.
Cash at the end of the third quarter of 2024 was $296 thousand
compared to $2.7 million at the close of the fourth quarter of
2023. We recorded investments in capital projects related to the
reduction of the carbon intensity of Aemetis ethanol and
construction of dairy digesters of $4.5 million for the third
quarter of 2024.
Financial Results for the Nine Months Ended September 30,
2024
Revenues were $220.6 million for the first three quarters of
2024, compared to $116.0 million for the first three quarters of
2023. The increase in revenue in 2024 was due to strong performance
from California Ethanol, India Biodiesel, and Dairy Renewable
Natural Gas throughout the nine months of 2024 compared to the same
period of 2023.
Gross profit for the first three quarters of 2024 was $1.5
million, compared to a gross profit of $1.2 million during the
first three quarters of 2023.
Selling, general and administrative expenses were $28.4 million
during the first three quarters of 2024, compared to $29.6 million
during the first three quarters of 2023, including $4.0 million of
fixed costs of goods sold charged to selling, general and
administrative during the Keyes plant maintenance period during
2023 and the recognition of a loss on asset disposals of $3.6
million during 2024.
Operating loss was $26.9 million for the first three quarters of
2024, compared to $28.4 million for the first three quarters of
2023.
Interest expense was $34.0 million during the first three
quarters of 2024, excluding accretion and other expenses of Series
A preferred units in our Aemetis Biogas LLC subsidiary, compared to
interest expense of $28.9 million during the first three quarters
of 2023. Additionally, our Aemetis Biogas LLC subsidiary recognized
$10.1 million of accretion and other expenses in connection with
preference payments on its preferred stock during the first three
quarters of 2024 compared to $20.2 million during the first three
quarters of 2023.
Net loss for the first three quarters of 2024 was $71.3 million,
compared to a net loss of $21.0 million during the same period of
2023.
Investments in capital projects of $13.5 million were made
during the first three quarters of 2024, including investments in
capital projects related to Aemetis Biogas of $10.9 million.
About Aemetis
Headquartered in Cupertino, California, Aemetis is a renewable
natural gas, renewable fuel and biochemicals company focused on the
operation, acquisition, development, and commercialization of
innovative technologies that replace petroleum-based products and
reduce greenhouse gas emissions. Founded in 2006, Aemetis is
operating and actively expanding a California biogas digester
network and pipeline system to convert dairy waste gas into
Renewable Natural Gas. Aemetis owns and operates a 65 million
gallon per year ethanol production facility in California’s Central
Valley near Modesto that supplies about 80 dairies with animal
feed. Aemetis owns and operates a 60 million gallon per year
production facility on the East Coast of India producing high
quality distilled biodiesel and refined glycerin for customers in
India and Europe. Aemetis is developing a sustainable aviation fuel
(SAF) and renewable diesel fuel biorefinery in California to
utilize renewable hydrogen, hydroelectric power, and renewable oils
to produce low carbon intensity renewable jet and diesel fuel. For
additional information about Aemetis, please visit
www.aemetis.com.
Non-GAAP Financial Information
We have provided non-GAAP measures as a supplement to financial
results based on GAAP. A reconciliation of the non-GAAP measures to
the most directly comparable GAAP measures is included in the
accompanying supplemental data. Adjusted EBITDA is defined as net
income/(loss) plus (to the extent deducted in calculating such net
income) interest expense, income tax expense, intangible and other
amortization expense, accretion expense, depreciation expense, loss
on asset disposal, gain on debt extinguishment, USDA cash grants
and share-based compensation expense.
Safe Harbor Statement
This news release contains forward-looking statements, including
statements regarding assumptions, projections, expectations,
targets, intentions or beliefs about future events or other
statements that are not historical facts. Forward-looking
statements include, without limitation, projections of financial
results in 2024 and future years; statements relating to the
development, engineering, financing, construction and operation of
the Aemetis ethanol, biodiesel, biogas, SAF and renewable diesel,
and carbon sequestration facilities; and our ability to promote,
develop and deploy technologies to produce renewable fuels and
biochemicals. Words or phrases such as “anticipates,” “may,”
“will,” “should,” “believes,” “estimates,” “expects,” “intends,”
“plans,” “predicts,” “projects,” “showing signs,” “targets,”
“view,” “will likely result,” “will continue” or similar
expressions are intended to identify forward-looking statements.
These forward-looking statements are based on current assumptions
and predictions and are subject to numerous risks and
uncertainties. Actual results or events could differ materially
from those set forth or implied by such forward-looking statements
and related assumptions due to certain factors, including, without
limitation, competition in the ethanol, biodiesel and other
industries in which we operate, commodity market risks including
those that may result from current weather conditions, financial
market risks, customer adoption, counter-party risks, risks
associated with changes to federal policy or regulation, and other
risks detailed in our reports filed with the Securities and
Exchange Commission, including our Annual Reports on Form 10-K, and
in our other filings with the SEC. We are not obligated, and do not
intend, to update any of these forward-looking statements at any
time unless an update is required by applicable securities
laws.
External Investor RelationsContact:Kirin SmithPCG
Advisory Group(646) 863-6519ksmith@pcgadvisory.com
Investor Relations/Media Contact:Todd Waltz(408)
213-0940investors@aemetis.com
(Tables follow)
AEMETIS, INC.CONSOLIDATED CONDENSED
STATEMENTS OF OPERATIONS(unaudited, in thousands, except per
share data)
|
|
For the three months endedSeptember
30, |
|
|
For the nine months endedSeptember
30, |
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
Revenues |
|
$ |
81,441 |
|
|
$ |
68,690 |
|
|
$ |
220,636 |
|
|
$ |
115,953 |
|
Cost of goods sold |
|
|
77,563 |
|
|
|
68,198 |
|
|
|
219,176 |
|
|
|
114,800 |
|
Gross profit |
|
|
3,878 |
|
|
|
492 |
|
|
|
1,460 |
|
|
|
1,153 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and
administrative expenses |
|
|
7,750 |
|
|
|
9,021 |
|
|
|
28,400 |
|
|
|
29,595 |
|
Operating loss |
|
|
(3,872 |
) |
|
|
(8,529 |
) |
|
|
(26,940 |
) |
|
|
(28,442 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other expense (income): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate expense |
|
|
10,096 |
|
|
|
8,749 |
|
|
|
29,092 |
|
|
|
24,126 |
|
Debt related fees and amortization expense |
|
|
1,651 |
|
|
|
1,433 |
|
|
|
4,892 |
|
|
|
4,732 |
|
Accretion and other expenses of Series A preferred units |
|
|
3,267 |
|
|
|
7,739 |
|
|
|
10,055 |
|
|
|
20,188 |
|
Other income |
|
|
(1,225 |
) |
|
|
(1,853 |
) |
|
|
(1,176 |
) |
|
|
(2,020 |
) |
Loss before income taxes |
|
|
(17,661 |
) |
|
|
(24,597 |
) |
|
|
(69,803 |
) |
|
|
(75,468 |
) |
Income tax expense (benefit) |
|
|
274 |
|
|
|
(55,308 |
) |
|
|
1,537 |
|
|
|
(54,490 |
) |
Net Income (loss) |
|
$ |
(17,935 |
) |
|
$ |
30,711 |
|
|
$ |
(71,340 |
) |
|
$ |
(20,978 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Income (loss) per common
share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
$ |
(0.38 |
) |
|
$ |
0.79 |
|
|
$ |
(1.60 |
) |
|
$ |
(0.56 |
) |
Diluted |
|
$ |
(0.38 |
) |
|
$ |
0.73 |
|
|
$ |
(1.60 |
) |
|
$ |
(0.56 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares
outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic |
|
|
47,216 |
|
|
|
38,881 |
|
|
|
44,517 |
|
|
|
37,504 |
|
Diluted |
|
|
47,216 |
|
|
|
41,841 |
|
|
|
44,517 |
|
|
|
37,504 |
|
AEMETIS, INC.CONSOLIDATED CONDENSED
BALANCE SHEETS(in thousands)
|
|
September 30, 2024 |
|
|
December 31, 2023 |
|
|
|
(Unaudited) |
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
296 |
|
|
$ |
2,667 |
|
Accounts receivable |
|
|
8,027 |
|
|
|
8,633 |
|
Inventories |
|
|
19,792 |
|
|
|
18,291 |
|
Prepaid and other current assets |
|
|
6,785 |
|
|
|
6,809 |
|
Total current assets |
|
|
34,900 |
|
|
|
36,400 |
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net |
|
|
195,939 |
|
|
|
195,108 |
|
Other assets |
|
|
16,586 |
|
|
|
11,898 |
|
Total assets |
|
$ |
247,425 |
|
|
$ |
243,406 |
|
|
|
|
|
|
|
|
|
|
Liabilities and
stockholders' deficit |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
37,254 |
|
|
$ |
32,132 |
|
Current portion of long term debt |
|
|
55,797 |
|
|
|
13,585 |
|
Short term borrowings |
|
|
21,418 |
|
|
|
23,443 |
|
Other current liabilities |
|
|
17,773 |
|
|
|
15,229 |
|
Total current liabilities |
|
|
132,242 |
|
|
|
84,389 |
|
|
|
|
|
|
|
|
|
|
Total long term liabilities |
|
|
374,092 |
|
|
|
375,994 |
|
|
|
|
|
|
|
|
|
|
Stockholders' deficit: |
|
|
|
|
|
|
|
|
Common stock |
|
|
48 |
|
|
|
41 |
|
Additional paid-in capital |
|
|
293,611 |
|
|
|
264,058 |
|
Accumulated deficit |
|
|
(546,745 |
) |
|
|
(475,405 |
) |
Accumulated other comprehensive loss |
|
|
(5,823 |
) |
|
|
(5,671 |
) |
Total stockholders' deficit |
|
|
(258,909 |
) |
|
|
(216,977 |
) |
Total liabilities and
stockholders' deficit |
|
$ |
247,425 |
|
|
$ |
243,406 |
|
RECONCILIATION OF ADJUSTED EBITDA TO NET
INCOME/(LOSS)(unaudited, in thousands)
|
|
For the three months ended September 30, |
|
|
For the nine months ended September 30, |
|
EBITDA Calculation |
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
(17,935 |
) |
|
$ |
30,711 |
|
|
|
(71,340 |
) |
|
|
(20,978 |
) |
Adjustments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and amortization expense |
|
|
11,747 |
|
|
|
10,182 |
|
|
|
33,984 |
|
|
|
28,858 |
|
Depreciation expense |
|
|
2,274 |
|
|
|
1,747 |
|
|
|
6,121 |
|
|
|
5,208 |
|
Accretion of Series A preferred units |
|
|
3,267 |
|
|
|
7,739 |
|
|
|
10,055 |
|
|
|
20,188 |
|
Loss on asset disposal |
|
|
- |
|
|
|
- |
|
|
|
3,644 |
|
|
|
- |
|
Gain on debt extinguishment |
|
|
(162 |
) |
|
|
- |
|
|
|
(162 |
) |
|
|
- |
|
Share-based compensation |
|
|
1,982 |
|
|
|
1,806 |
|
|
|
6,928 |
|
|
|
6,223 |
|
Intangibles amortization expense |
|
|
12 |
|
|
|
11 |
|
|
|
36 |
|
|
|
35 |
|
USDA cash grants |
|
|
- |
|
|
|
(1,774 |
) |
|
|
- |
|
|
|
(1,774 |
) |
Income tax expense |
|
|
274 |
|
|
|
(55,308 |
) |
|
|
1,537 |
|
|
|
(54,490 |
) |
Total adjustments |
|
|
19,394 |
|
|
|
(35,597 |
) |
|
|
62,143 |
|
|
|
4,248 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA |
|
$ |
1,459 |
|
|
$ |
(4,886 |
) |
|
|
(9,197 |
) |
|
|
(16,730 |
) |
PRODUCTION AND PRICE
PERFORMANCE(unaudited)
|
|
Three Months ended September 30, |
|
|
Nine Months ended September 30, |
|
|
|
2024 |
|
|
2023 |
|
|
2024 |
|
|
2023 |
|
Ethanol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gallons sold (in millions) |
|
|
15.5 |
|
|
|
13.8 |
|
|
|
44.4 |
|
|
|
16.7 |
|
Average sales price/gallon |
|
$ |
2.12 |
|
|
$ |
2.64 |
|
|
$ |
1.97 |
|
|
$ |
2.72 |
|
Percent of nameplate capacity |
|
|
113 |
% |
|
|
100 |
% |
|
|
108 |
% |
|
|
91 |
% |
WDG |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Tons sold (in thousands) |
|
|
106 |
|
|
|
98.0 |
|
|
|
305 |
|
|
|
122.0 |
|
Average sales price/ton |
|
$ |
84 |
|
|
$ |
96 |
|
|
$ |
90 |
|
|
$ |
98 |
|
Delivered Cost of
Corn |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bushels ground (in millions) |
|
|
5.5 |
|
|
|
5.0 |
|
|
|
15.6 |
|
|
|
6.4 |
|
Average delivered cost / bushel |
|
$ |
6.07 |
|
|
$ |
7.48 |
|
|
$ |
6.25 |
|
|
$ |
7.34 |
|
Dairy Renewable
Natural Gas |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
MMBtu produced (in thousands) |
|
|
86.6 |
|
|
|
66.6 |
|
|
|
236.3 |
|
|
|
142.0 |
|
MMBtu stored as inventory (in thousands) |
|
|
67.6 |
|
|
|
67.2 |
|
|
|
67.6 |
|
|
|
67.2 |
|
MMBtu sold (in thousands) |
|
|
86.0 |
|
|
|
66.6 |
|
|
|
234.8 |
|
|
|
142.0 |
|
Biodiesel |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Metric tons sold (in thousands) |
|
|
26.0 |
|
|
|
15.5 |
|
|
|
73.5 |
|
|
|
42.1 |
|
Average Sales Price/Metric ton |
|
$ |
1,198 |
|
|
$ |
1,247 |
|
|
$ |
1,167 |
|
|
$ |
1,265 |
|
Percent of Nameplate Capacity |
|
|
69.3 |
% |
|
|
41.0 |
% |
|
|
65.4 |
% |
|
|
21.0 |
% |
Refined
Glycerin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Metric tons sold (in thousands) |
|
|
1.5 |
|
|
|
1.4 |
|
|
|
5.4 |
|
|
|
2.9 |
|
Average Sales Price/Metric ton |
|
$ |
720 |
|
|
$ |
623 |
|
|
$ |
621 |
|
|
$ |
651 |
|
Aemetis (NASDAQ:AMTX)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024
Aemetis (NASDAQ:AMTX)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024